NCT04857294

Brief Summary

Temporomandibular joint (TMJ) discectomy is one of the most popular surgical techniques for painful TMJ. Previous studies have demonstrated predictable results of discectomy with optimal results in pain reduction and maximum mouth opening (MMO) improvement. However, those studies had most of the times varied inclusion criteria. A 4-year prospective study was designed including patients treated with unilateral TMJ discectomy without interposal material as the first surgical procedure for two specific intra-articular diagnosis: disc perforation and disc fragmentation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 9, 2015

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 11, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 10, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 23, 2021

Completed
Last Updated

April 23, 2021

Status Verified

April 1, 2021

Enrollment Period

5.4 years

First QC Date

April 10, 2021

Last Update Submit

April 20, 2021

Conditions

Keywords

TemporomandibularTMJ DiscectomyTMJ MeniscectomyTMJ Surgery

Outcome Measures

Primary Outcomes (2)

  • Pain (Visual Analogue Scale (0,10)

    VAS, 0-10, with 0 being no pain and 10 having maximum unbearable pain

    Pre-surgery

  • Pain (Visual Analogue Scale (0,10)

    VAS, 0-10, with 0 being no pain and 10 having maximum unbearable pain

    Through study completion, an average of 2 years

Secondary Outcomes (4)

  • Maximum mouth opening (MMO, mm)

    Pre-surgery

  • Maximum mouth opening (MMO, mm)

    Through study completion, an average of 2 years

  • Muscle tenderness (0-3 scale)

    Pre-surgery

  • Muscle tenderness (0-3 scale)

    Through study completion, an average of 2 years

Study Arms (1)

Discectomy

EXPERIMENTAL

Unilateral Discectomy

Procedure: TMJ unilateral discectomy

Interventions

All patients underwent general anesthesia with nasotracheal intubation, managed in most cases with intravenous anesthesia protocol, usually with remifentanil infusion. Intraoperative steroids, usually dexamethasone, were administered primarily to minimize postoperative swelling. A classic preauricular incision or a root of helix inter tragus notch incision (RHITNI) was used in most cases, as previously described. No bandage or special care was performed after the surgery. No air washing restrictions were recommended.

Discectomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years old;
  • Unilateral TMJ pain \>7 (0-10 VAS) and/or MMO \< 30mm;
  • MRI presenting unilateral disc perforation or disc fragmentation
  • Clinical and imaging examination with criteria for unilateral TMJ discectomy

You may not qualify if:

  • Previous TMJ surgical intervention;
  • Concomitant contralateral surgery;
  • Age \< 18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Português da Face

Lisbon, 1050-227, Portugal

Location

MeSH Terms

Conditions

Temporomandibular Joint Disorders

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic Diseases

Study Officials

  • David Ângelo, MD, PhD

    Instituto Português da Face

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Prospective Study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 10, 2021

First Posted

April 23, 2021

Study Start

July 9, 2015

Primary Completion

December 11, 2020

Study Completion

January 31, 2021

Last Updated

April 23, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations